Fundies.
English

BRAINSTORM CELL THERAPEUTICS INC.

EDGAR
BCLI Quarterly report (10-Q) · filed 2026-08-14

132 filing records in this dataset, filed from 2001-11-08 to 2026-08-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist
Cash and cash equivalents
22 thousand Unit_Standard_USD_c32AZV-wXEqFuyuPeizVIA Source
Exact value

22000 Unit_Standard_USD_c32AZV-wXEqFuyuPeizVIA

Long-term debt including current maturities
Not available
Shares outstanding
11 million Unit_Standard_shares_a8teLjW-5Ea-GbfS8tBd7g Source
Exact value

11034775 Unit_Standard_shares_a8teLjW-5Ea-GbfS8tBd7g

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-14.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 2 of 11 periods available· newest 2025-12-31
  • Net income: 2 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 2 of 11 periods available· newest 2023-12-31
  • Total assets: Multiple units; comparison withheld· newest 2025-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Current assets: Multiple units; comparison withheld· newest 2025-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    +Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA 1.32 million

    Prior period

    −Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA 11.62 million

    –

    Current period

    −Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA 10.31 million

    –

    Exact inputs and evidence

    -10307000 − -11623000 = 1316000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA

    -11623000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -10307000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA 2.12 million

    Prior period

    −Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA 9.09 million

    –

    Current period

    −Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA 6.98 million

    –

    Exact inputs and evidence

    -6975000 − -9093000 = 2118000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA

    -9093000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -6975000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2024 2024-01-01 – 2024-12-31
−Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA 11.62 million
Exact value

Exact value: -11623000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA

2024-01-01 – 2024-12-31: -11623000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA 9.09 million
Exact value

Exact value: -9093000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA

2024-01-01 – 2024-12-31: -9093000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2025 2025-01-01 – 2025-12-31
−Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA 10.31 million
Exact value

Exact value: -10307000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA

2025-01-01 – 2025-12-31: -10307000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA 6.98 million
Exact value

Exact value: -6975000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA

2025-01-01 – 2025-12-31: -6975000 Unit_Standard_USD_GFAP1PcXRUqzvDuNZM6GUA Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

132 filings · 4,258 latest values · 4,258 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001137883, 1137883, BCLI, bcli, edgar:1137883

Also known as BRAINSTORM CELL THERAPEUTICS INC, BRAINSTORM CELL THERAPEUTICS INC., BRAINSTORM CELL THERAPEUTICS INC., Brainstorm Cell Therapeutics Inc., GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC